NovaBone received FDA approval for the NovaBone Putty MIS delivery system for minimally invasive orthopedic surgery, according to a company news release.
The new system includes a syringe with pre-loaded NovaBone Putty and six millimeter diameter cannulas at varying lengths for bone grafting at the surgical site. The system delivers an osteoconductive matrix to stimulate the osteoblastic activity at the site.
The product is approved for surgery of the extremities, pelvis and posterolateral spine.
Read the release on the NovaBone Putty MIS delivery system.
Read other coverage on orthopedic device clearance:
- RSB Spine's InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
- Wenzel Spine Receives FDA Clearance on Spinal System
- 32 Orthopedic and Spine Devices Receive FDA Clearance in August
The new system includes a syringe with pre-loaded NovaBone Putty and six millimeter diameter cannulas at varying lengths for bone grafting at the surgical site. The system delivers an osteoconductive matrix to stimulate the osteoblastic activity at the site.
The product is approved for surgery of the extremities, pelvis and posterolateral spine.
Read the release on the NovaBone Putty MIS delivery system.
Read other coverage on orthopedic device clearance:
- RSB Spine's InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
- Wenzel Spine Receives FDA Clearance on Spinal System
- 32 Orthopedic and Spine Devices Receive FDA Clearance in August